New jersey

Index
Globenewswire

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

Globenewswire

Verisk Unveils First-of-Its-Kind SRCC Catastrophe Model for the U.S. to Quantify Political Violence Risks

Globenewswire

Trigyn Technologies Appoints Vikram Chandna as Chief Executive Officer

Globenewswire

Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase

Globenewswire

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

Globenewswire

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

Globenewswire

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

Globenewswire

Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

Globenewswire

UPDATE -- RAM Photonics Industrial Launches Mass Production of 2D Fiber Arrays for AI and DC

Globenewswire

Verisk Nominates Christopher Perry and Sabra Purtill to the Company’s Board of Directors

Globenewswire

Folk Maritime Becomes Middle East’s First Dry Container Fleet to Deploy ORBCOMM®’s Smart Container Technology

Globenewswire

Vanotech Appoints Matthew Schiller to Lead Business Development

Globenewswire

ORBCOMM® Announces OGx Enhancements to Improve Satellite IoT Accessibility

Globenewswire

Synchronoss Memperkenalkan Capsyl Cloud di MWC Barcelona – Solusi Cloud Pribadi Turn-Key untuk Operator Global

Globenewswire

Synchronoss Unveils Capsyl Cloud at MWC Barcelona – A Turn-Key Personal Cloud Solution for Global Operators

Globenewswire

Horizon Group USA Names Big Wheel Toys as Australian Distributor

Globenewswire

Synchronoss Technologies Mengumumkan Tanggal Panggilan Konferensi Laporan Pendapatan Kuartal Keempat dan Tahun Penuh 2024

Globenewswire

Synchronoss Technologies Announces Fourth Quarter and Full Year 2024 Earnings Call Date

Globenewswire

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY(R) (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

Globenewswire

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Globenewswire

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

Globenewswire

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

Globenewswire

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

Globenewswire

Verisk Wildfire Model is the First Catastrophe Model Under Review for Insurance Ratemaking in the State of California

Globenewswire

New BASF VOC2.0™ Catalyst Technology Now Available in the VOZC™ Converter on Airbus A320 Fleet